Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study

BACKGROUND: Biosimilars are expected to emerge as a rapidly growing segment of the biopharmaceutical industry. However, the biosimilar industry faces multiple challenges and obstacles in developing and marketing these complex products. Divergent regulatory framework in emerging countries adds to rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahalkar, Hasumati, Sheppard, Alan, Lopez-Morales, Carlos Augusto, Lobo, Luciano, Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295548/
https://www.ncbi.nlm.nih.gov/pubmed/34292558
http://dx.doi.org/10.1007/s40290-021-00395-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295548/
https://www.ncbi.nlm.nih.gov/pubmed/34292558
http://dx.doi.org/10.1007/s40290-021-00395-8

Ejemplares similares